ESMO新知: 免疫療法能否預防肺癌? Can Immunotherapy Prevent Lung Cancer After GGO Detection by LDCT?

ESMO新知: 免疫療法能否預防肺癌? Can Immunotherapy Prevent Lung Cancer After GGO Detection by LDCT?

2 影片觀看·2026年2月11日

這段影片將介紹歐洲腫瘤醫學會(ESMO)中關於低劑量電腦斷層掃描(LDCT)發現磨玻璃樣病灶(GGO)後的免疫療法應用。影片將探討免疫藥物在這種情況下是否能有效預防肺癌的進展,並分析最新研究的結果與臨床實踐的可能性。我們將深入解讀這一潛在的治療方法,並幫助觀眾了解GGO和免疫療法之間的關聯。

This video will discuss the insights from the European Society for Medical Oncology (ESMO) regarding the use of immunotherapy after the detection of ground-glass opacities (GGO) by low-dose CT (LDCT). The video will explore whether immunotherapy can effectively prevent the progression of lung cancer in these cases, analyzing the latest research and its potential clinical applications. We will delve into this promising treatment approach and help viewers understand the connection between GGO and immunotherapy.

時間軸